UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

European journal of cancer (1990), 2021-07, Vol.152, p.18-25

2021

Volltextzugriff (PDF)

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

Cancers, 2020-11, Vol.12 (12), p.3538

2020

Volltextzugriff (PDF)

The many unanswered questions related to the German skin cancer screening programme

European journal of cancer (1990), 2016-09, Vol.64, p.83-88

2016

Volltextzugriff (PDF)

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

European journal of cancer (1990), 2010-01, Vol.46 (2), p.270-283

2010

Volltextzugriff (PDF)

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Cancers, 2024-01, Vol.16 (3), p.606

2024

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

Cancers, 2020-02, Vol.12 (3), p.540

2020

Volltextzugriff (PDF)

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

Neuroradiology, 2019-07, Vol.61 (7), p.775-782

2019

Volltextzugriff (PDF)

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

Cellular physiology and biochemistry, 2018-01, Vol.51 (2), p.543-556

2018

Volltextzugriff (PDF)

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Cancers, 2020-04, Vol.12 (5), p.1101

2020

Volltextzugriff (PDF)

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Cancers, 2021-11, Vol.13 (21), p.5411

2021

Volltextzugriff (PDF)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

Frontiers in immunology, 2022-07, Vol.13, p.906352-906352

2022

Volltextzugriff (PDF)

Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions

Diagnostics (Basel), 2019-08, Vol.9 (3), p.103

2019

Volltextzugriff (PDF)

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Frontiers in oncology, 2021-03, Vol.11, p.643156

2021

Volltextzugriff (PDF)

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)

Journal of translational medicine, 2020-09, Vol.18 (1), p.346-346, Article 346

2020

Volltextzugriff (PDF)

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1780-1787

2010

Volltextzugriff (PDF)

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

EBioMedicine, 2016-06, Vol.8 (C), p.132-149

2016

Volltextzugriff (PDF)

Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells

Biology open, 2018, Vol.7 (6), p.bio032656-bio032656

2018

Volltextzugriff (PDF)

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2253

2020

Volltextzugriff (PDF)

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy

Reviews in endocrine & metabolic disorders, 2017-12, Vol.18 (4), p.517-532

2017

Volltextzugriff (PDF)

Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland

European journal of cancer (1990), 2023-04, Vol.183, p.60-68

2023

Volltextzugriff (PDF)

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

Journal of clinical oncology, 2015-04, Vol.33 (10), p.1191-1196

2015

Volltextzugriff (PDF)

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Journal of clinical oncology, 2019-11, Vol.37 (32), p.3000-3008

2019

Volltextzugriff (PDF)

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma

Journal of clinical oncology, 2022-12, Vol.40 (36), p.4178-4188

2022

Volltextzugriff (PDF)

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma

European journal of cancer (1990), 2020-02, Vol.126, p.33-44

2020

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

ThemaDermatology

ThemaMetastasis

ThemaPrognosis

KollektionIngenta.com

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(80)
Buchkapitel
(1)

Sprache

Englisch
(81)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Oncology
(55)
Humans
(50)
Melanoma
(42)
Melanoma - Drug Therapy
(21)
Female
(19)
Male
(18)
Aged
(17)
Immunotherapy
(17)
Middle Aged
(17)
Melanoma - Pathology
(14)
Adult
(13)
Skin Cancer
(12)
Melanoma - Mortality
(11)
Patients
(11)
Skin Neoplasms - Drug Therapy
(11)
Hematology, Oncology And Palliative Medicine
(10)
Skin Neoplasms - Pathology
(10)
Tumors
(10)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943–2036

Disulfiram as a Therapeutic Agent for Metastatic Malignant Melanoma-Old Myth or New Logos?

The many unanswered questions related to the German skin cancer screening programme

Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline

Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma

Meningeal enhancement depicted by magnetic resonance imaging in tumor patients: neoplastic meningitis or therapy-related enhancement?

6- and 8-Prenylnaringenin, Novel Natural Histone Deacetylase Inhibitors Found in Hops, Exert Antitumor Activity on Melanoma Cells

Are Pathogenic Germline Variants in Metastatic Melanoma Associated with Resistance to Combined Immunotherapy?

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade

Diagnostic Performance of a Support Vector Machine for Dermatofluoroscopic Melanoma Recognition: The Results of the Retrospective Clinical Study on 214 Pigmented Skin Lesions

Case Report: Combined CDK4/6 and MEK Inhibition in Refractory CDKN2A and NRAS Mutant Melanoma

Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)

Large Randomized Study of Thymosin α 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma

A Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib

Embryonic bone morphogenetic protein and nodal induce invasion in melanocytes and melanoma cells

A Systematic Review and Meta-Analysis of Interventions for Actinic Keratosis from Post-Marketing Surveillance Trials

Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy

Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland

Five-year survival rates for treatment-naive patients with advanced melanoma who received ipilimumab plus dacarbazine in a phase III trial

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

COLUMBUS 5-Year Update: A Randomized, Open-Label, Phase III Trial of Encorafenib Plus Binimetinib Versus Vemurafenib or Encorafenib in Patients With BRAF V600-Mutant Melanoma

Update on tolerability and overall survival in COLUMBUS: landmark analysis of a randomised phase 3 trial of encorafenib plus binimetinib vs vemurafenib or encorafenib in patients with BRAF V600–mutant melanoma

Aktive Filter

Suchergebnisse filtern